Transpharmation Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 150

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

  • Investments
  • 2

Transpharmation General Information

Description

Operator of a contract research organization intended to provide drug development research services. The company's core therapeutic expertise includes EEG, cognition, epilepsy, pain, neurodegeneration, neuroinflammation and anxiety/mood disorders, including treatment-resistant depression, sleep disorders and schizophrenia.

Contact Information

Website
www.transpharmation.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 2 Royal College Street
  • London NW1 0NH
  • England, United Kingdom
+44 01304
Primary Industry
Other Pharmaceuticals and Biotechnology
Parent Company
Vivocore
Corporate Office
  • 2 Royal College Street
  • London NW1 0NH
  • England, United Kingdom
+44 01304

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Transpharmation Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Transpharmation‘s full profile, request access.

Request a free trial

Transpharmation Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Transpharmation Acquisitions (2)

Transpharmation’s most recent deal was a Merger/Acquisition with OrganoTherapeutics. The deal was made on 23-Oct-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
OrganoTherapeutics 23-Oct-2026 Merger/Acquisition Biotechnology
Saretius 02-Apr-2025 Merger/Acquisition Drug Delivery
To view Transpharmation’s complete acquisitions history, request access »

Transpharmation Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
OrganoTherapeutics Esch-sur-Alzette, Luxembourg 2019
Transpharmation Ireland Dublin, Ireland 2014
Saretius Reading, United Kingdom 2008

Transpharmation FAQs

  • When was Transpharmation founded?

    Transpharmation was founded in 2010.

  • Where is Transpharmation headquartered?

    Transpharmation is headquartered in London, United Kingdom.

  • What is the size of Transpharmation?

    Transpharmation has 150 total employees.

  • What industry is Transpharmation in?

    Transpharmation’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Transpharmation a private or public company?

    Transpharmation is a Private company.

  • What is Transpharmation’s current revenue?

    The current revenue for Transpharmation is .

  • When was Transpharmation acquired?

    Transpharmation was acquired on 07-Feb-2022.

  • Who acquired Transpharmation?

    Transpharmation was acquired by Vivocore.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process